Seeking Alpha

ADHD
  Alcobra Ltd. - NASDAQ

9/16/2014, 3:31 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ADHD vs. ETF Alternatives
Company Description
Alcobra Ltd is a biopharmaceutical company which engaged in the development and commercialization of its proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome.
Sector: Healthcare
Country: Israel